Valuation : DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.4B 3.19B 2.74B 2.58B 2.36B 4.41B 301B 4.42B 30.49B 11.83B 154B 11.97B 11.71B 497B P/E 2026 *
14.4x
P/E 2027 * 12.5x
Enterprise Value 18.06B 2.69B 2.31B 2.18B 1.99B 3.72B 254B 3.73B 25.73B 9.99B 130B 10.1B 9.88B 420B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.54x
Free-Float
34.77%
Yield 2026 *
5.01%
Yield 2027 * 5.55%
1 day+1.51%
1 week+3.53%
Current month+1.84%
1 month+2.90%
3 months+17.95%
6 months-4.47%
Current year+6.64%
1 week 17.75
Extreme 17.75
18.9
1 month 17.33
Extreme 17.33
19.99
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 15/07/2013
Director/Board Member 63 07/08/2016
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%+3.53%+9.44%-27.45% 3.19B
+2.94%+1.04%-41.96%-13.11% 15.07B
+0.44%-1.03%-18.22%-9.97% 6.55B
+3.29%-0.16%-51.62%-33.19% 6.47B
+0.04%+0.09%-7.92%-21.17% 4.14B
+0.93%-1.44%-19.73%-39.43% 3.17B
-1.50%-0.23%-44.66%-26.72% 2.94B
+1.59%+10.01%+44.52% - 2.58B
+2.42%-5.49%-16.90%-10.30% 2.5B
+2.13%+9.59%+71.45%+129.43% 1.5B
Average +1.38%+1.20%-7.56%-5.77% 4.81B
Weighted average by Cap. +1.77%+0.70%-22.91%-15.11%

Financials

2026 *2027 *
Net sales 29.54B 4.4B 3.79B 3.56B 3.25B 6.09B 415B 6.1B 42.09B 16.33B 213B 16.52B 16.16B 687B 32.52B 4.84B 4.17B 3.92B 3.58B 6.7B 457B 6.72B 46.34B 17.98B 235B 18.19B 17.79B 756B
Net income 1.49B 221M 190M 179M 164M 306M 20.9B 307M 2.12B 822M 10.72B 831M 813M 34.54B 1.71B 255M 219M 206M 189M 353M 24.07B 354M 2.44B 946M 12.35B 957M 936M 39.78B
Net Debt -3.34B -498M -428M -403M -368M -688M -46.97B -690M -4.76B -1.85B -24.1B -1.87B -1.83B -77.64B -3.76B -560M -482M -453M -414M -775M -52.88B -777M -5.36B -2.08B -27.13B -2.1B -2.06B -87.41B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
04/09/26 CN¥18.79 +1.51% 6,119,561
03/09/26 CN¥18.51 +2.38% 7,319,414
02/09/26 CN¥18.08 -1.79% 6,506,254
01/09/26 CN¥18.41 -0.22% 8,020,937
31/08/26 CN¥18.45 +1.65% 11,587,958
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.79CNY
Average target price
23.75CNY
Spread / Average Target
+26.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock